PHARMACOTHERAPY IN OLD AGE

1 Stevenson IH SAM Salem Shepherd AMM. Studies on drug absorption and metabolism in the elderly. In: Crooks J, Stevenson IH, editors. Drugs and the elderly. Vol. 6. London: Macmillan; 1979; 51-63.

2 Bianchine JR LR Calimlim Morgan JP Metabolism and absorption of L-3, 4 dihydroxyphenylalanine in patients with Parkinson’s disease. Ann N Y Acad Sci 1971; 179: 126-40.

3 Ochs HR DJ Greenblatt Allen MD Effect of age and Billroth gastrectomy on absorption of desmethyldiazepam from clorazepate. Clin Pharmacol Ther 1979; 26:449-56.

4 Forbes GB Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970; 19(9):653-63.

5 Shock NW DM Watkin ,Yiengst MJ Age differences in water content of the body as related to basal oxygen consumption in males. J Gerontol 1963; 18:1-8.

6 Cusack B J Kelly O'Malley K Digoxin in the elderly: pharmacokinetic consequences of old age. Clin Pharmacol Ther 1979; 25:772-6.

7 Vestal RE EA McGuire Tobin JD Aging and ethanol metabolism. Clin Pharmacol Ther 1977; 21:343-54.

8 Owen JA DS Sitar Berger L Age-related morphine kinetics. Clin Pharmacol Ther 1983; 34:364-8.

9 Greenblatt MM MD Allen Harmatz JS Diazepam disposition determinants. Clin Pharmacol Ther 1980; 27:301-12.

10Nation RL,Triggs EJ, Selig M. Lignocaine kinetics in cardiac patients and aged subjects. Br J Clin Pharmacol 1977; 4:439-48.

11Christensen JH,Andreason S, Jansen JA. Pharmacokinetics and pharmacodynamics of thiopentone. Anaesthesia 1982; 37:398-404.

12 Ochs HR DJ Greenblatt Divoll M Diazepam kinetics in relation to age and sex. Pharmacology 1981; 23:24-30.

13 Greenblatt DJ. Reduced serum albumin concentration in the elderly: a report from Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc 1979; 27:20-2.

14Miller AK,Adir J, Vestal RE. Tolbutamide binding to plasma proteins of young and old human subjects. J Pharm Sci 1978; 67: 1192-3.

15 Nation RL B Learoyd Barber J The pharmacokinetics of chlormethiazole following intravenous administration in the aged. Eur J Clin Pharmacol 1976; 10:407-15.

16 Upton RA RL Williams Kelly J Naproxen pharmacokinetics in the elderly. Br J Clin Pharmacol 1984; 18:207-14.

17 Mather LE GT Tucker Pflug AE Meperidine kinetics in man: intravenous injection in surgical patients and volunteers. Clin Pharmacol Ther 1975; 17:21-30.

18 Hayes MJ MJS Langman Short AH. Changes in drug metabolism with increasing age. II. Phenytoin clearance and protein binding. Br J Pharmacol 1975; 2:73-9.

19 Netter P G Faure Regent MC Salicylate kinetics in old age. Clin Pharmacol Ther 1985; 38:6-11.

20 Abernethy DR Kerzner L. Age effects on alpha-1 -acid glycoprotein concentration and imipramine plasma protein binding. J Am Geriatr Soc 1984; 32:705-8.

21 Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989; 321:303-9.

22 Calloway NO CF Foley Lagerbloom P. Uncertainties in geriatric data: organ size. J Am Geriatr Soc 1965; 13:20.

23 Geokas MC Haverback BH. The ageing gastrointestinal tract. Am J Surg 1969; 117:881-92.

24 Whittaker JA Evans DDP. Genetic control of phenylbutazone metabolism in man. Br Med J 1970; 4:323-8.

25 Salem SAM Rajjaybun P Shepherd AMM Reduced induction of drug metabolism in the elderly. Age Ageing 1978; 7:68-73.

26 Castledon CM George CF. The effect of aging on the hepatic clearance of propranolol. Br J Pharmacol I979; 7X49-54.

27 Irvine RE J Grove Toseland PA Effect of age on the hydroxylation of amylobarbitone sodium in man. Br J Clin Pharmacol 1975; 2:303-6.

28Wood AJ,Vestal RE,Wilkinson GR Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther 1979; 26: 16-20.

29 Roberts RK GR Wilkinson Branch RA Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium). Gastroenterology 1978; 75:479-85.

30 Crooks J K Omalley Stevenson IH. Pharmacokinetics in the elderly. Clin Pharmacokinet 1976; 1:280-96.

31 Divoll M DR Abernathy Ameer B Acetaminophen kinetics in the elderly. Clin Pharmacol Ther 1982; 31: 151-6.

32 Mayersohn M. Drug disposition. In: Conrad KA, Bressler R, editors. Drug therapy in the elderly. St Louis: CV Mosby; 1982; 31-63.

33 Shull HJ GR Wilkinson Johnson R Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 1976; 84:420-5.

34 Paulsen O Nilsson LG. Distribution of acetylator phenotype in relation to age and sex in Swedish patients. Eur J Clin Pharmacol 1985; 28:311-15.

35 Robert C A Saint-Aubin Houin G Metabolisme de l’isomazide chez le vieillard, consequences pratiques. Revue Geriatr 1980; 5:211-6.

36 Rowe JW R Andres ,Tobin JD Age-adjusted standards for creatinine clearance. Ann Intern Med 1976; 84:567-9.

37 Davies DF Age changes in glomerular filtration rate Shock NW flow effective renal plasma excretory tubular capacity in adult males. J Clin Invest 1950; 29:496.

38 Hollenberg NK DF Adams Solomon HS Senescence and the renal vasculature in normal man. Circ Res 1974; 34:309-16.

39 Cockcroft DW Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31 -41.

40 Chaudhry AY RF Bing Castleden CM The effect of aging on the response to furosemide in normal subjects. Eur J Clin Pharmacol 1984; 27:303-6.

41 Epstein M Hollenberg NK. Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med 1976; 87(3):411-17.

42 Phillips PA BJ Rolls Ledingham JG Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 1984; 311(12):753-9.

43 Caird FI JR Andrews Kennedy RD. Effect of posture on blood pressure in the elderly. Br Heart J 1973; 35:527-30.

44 Klausner SC Schwartz AB. The aging heart. Clin Geriatr Med 1985; 1(1):119-41.

45 Harper CM PA Newton Walsh JR. Drug-induced illness in the elderly. Postgrad Med 1989; 86(2):245-56.

46 Ray WA MR Griffin Shorr RI. Adverse drug reactions and the elderly. Health Affairs 1990; 9: 114-22.

47 Schwartz JB Abernethy DR. Cardiac drugs: adjusting their use in aging patients. Geriatrics 1987;42(8):31-40.

48 Bend F. Clinical aspects of the aging heart. Z Kardiol 1985; 74(Suppl 1):49-54.

49 Docherty JR. Ageing and the cardiovascular system. J Auton Pharmacol 1986; 6:77-84.

50 Lakatta EG G Gerstenblith Angell CS Diminished inotropic response of the aged myocardium to catecholamines. Circ Res 1975; 36(2):262-9.

51 Vestal RE AJ Wood Shand DG. Reduced β-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181-6.

52 Stratton JR MD Cerqueira Scwartz RS Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 1992; 86:504-12.

53 Feldman RD LE Limbird Nadeau JL. Alterations in leucocyte beta-receptor affinity with ageing: A potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med 1984; 310:815-9.

54 Bertel O FR Buhler Kiowski W Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 1980; 2: 130-8.

55 Pan HYM BB Hoffman Pershe RA Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther 1986; 239:802-7.

56 Ullah MI GB Newman Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 1981; 36(7):523-9.

57 Buehler FR F Burkart Lutold B Antihypertensive beta blocking action is related to renin and age: a pharmacologic tool to identify pathogenic mechanisms in essential hypertension. Am J Cardiol 1975; 36(5):653-69.

58 Krall JF M Connelly Weisbart R Age-related elevation of plasma catecholamine concentrations and reduced responsiveness of lymphocyte adenylate cyclase. J Clin Endocrinol Metab 1981; 52(5):863-7.

59 Feldman RD LE Limbird Nadeau J Alterations in leukocyte beta-receptor affinity with aging: a potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med 1984; 310:815-19.

60 Meredith PA HL Elliott Ahmed JD Age and the antihypertensive efficacy of verapamil - integrated pharmacokinetic - pharmacodynamic approach. J Hypertension 1987; 5(Suppl 5):S219-21.

61 Abernethy DR JB Schwartz Todd EL Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Ann Intern Med 1986; 105:329-36.

62 Montamat SC Abernethy DR. Calcium antagonists in geriatric patients: diltiazem in elderly patients with hypertension. Clin Pharmacol Ther 1989; 45:682-91.

63 Schwartz JB Abernethy D. Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension. Am J Cardiol 1987; 59: 1111-7.

64 Lyons D S Roy Patel M Impaired nitric oxide mediated vasodilation and total body nitric oxide production in healthy old age. Clin Sci 1997; 93(6):519-25.

65 McGeer PL EG McGeer Suzuki J Aging, Alzheimer’s disease, and the cholinergic system of the basal forebrain. Neurology I984; 34(6):741-5.

66 Rinne JO. Muscarinic and dopaminergic receptors in aging human brain. Brain Res 1987; 404: 161-8.

67 Dauchot P Gravenstein JS. Effects of atropine on the electrocardiogram in different age groups. Clin Pharmacol Ther 1971; 12:274-80.

68 Ray PG KJ Meador Loring DW Central anticholinergic hypersensitivity in aging. J Geriatr Psych Neurol 1992; 5(2):72-7.

69 Joseph JA RE Berger Engle BT Age-related changes in the nigrostriatum: a behavioral and biochemical analysis. J Gerontol 1978; 33:643-9.

70 Morgan DG PC May Dopamine Finch CE. systems serotonin in human and rodent brain: Effects of age and neurodegenerative disease. J Am Geriat Soc 1987; 35:334-45.

71Mackay AVP Iversen LL, Rossor M Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 1982; 39:991-7.

72 Palmer AM DeKosky ST. Neurochemistry. In: Pathy MSJ, editor. Principles and practice of geriatric medicine. Chichester:John Wiley &Sons Ltd; 1998.

73 Kaplan AP. Drug-induced skin disease. J Allergy Clin Immunol 1984; 74(4):573-9.

74 Robinson DS A Nies Davis JM Aging monoamines and monoamin oxidase. Lancet 1972; 1:290-1.

75 DeKosky ST Palmer AM. Neurochemistry of aging. In: Albert ML and Knoefel JE, editors. Clinical neurology of aging New York: Oxford University Press; 1994; 79-101.

76 Bertler A. Occurrence and localization of catecholamines in the human brain. Acta Physiol Scand 1961; 51:97-107.

77 Arranz B A Eriksson Mellerup E Effect of aging in human pre- and postsynaptic serotonin binding sites. Brain Research 1993; 620(1): 163-6.

78Cutler NR,Zavadil III AP, Eisdorfer C Concentrations of desipramine in elderly women. Am J Psychiat 1981; 138(9): 1235-7.

79 Salzman C. Neuropsychopharmacology. In: Katzman R, Rowe JW, editors. Principles of geriatric neurology. Philadelphia: FA Davis; 1992; 59-72.

80 Spokes EGS NJ Garrett Rossor MN Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington’s chorea subjects. J Neurol Sci 1980; 48:303-13.

81 Bowen DM JA Spillane Curson G Accelerated ageing or selective neuronal loss as an important cause of dementia. Lancet 1979; i:11-14.

82 Suhara T O Inoue Kobayashi K No age-related changes in human benzodiazepine receptor binding measured by PET with [IIC]Ro 15-4513. Neurosci Lett 1993; 159(1-2):207-10.

83 Evans JG Nitrazepam Jarvis EH. and the elderly. Br Med J 1972; 4(838):487.

84 Kaiko RF SL Wallenstein Rogers AG Narcotics in the elderly. Med Clin North Am 1982; 66: 1079-89.

85 Scott JC Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240(1):237-9.

86 Meyer BR M Levin Drayer DE Optimising metoclopramide control of cisplatin-induced emesis. Ann Intern Med 1984; 100:393-5.

87 Portenoy RK. Optimal pain control in elderly cancer patients. Geriatrics 1987; 42(5):33-44.

88 Bender AD. Pharmacologic aspects of aging: a survey of the effect of increasing age on drug activity in adults. J Am Geriatr Soc 1964; 12: 114-34.

89 Shepherd AMM DS Hewick Moreland TA Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol 1977; 4:315-20.

90 Lamy PP. Drug therapy in the elderly. Pharmacy Int 1986; 7:46-59.

91 Collins KJ C Dore Exton-Smith AN Accidental hypothermia and impaired temperature homeostasis in the elderly. BMJ 1977; 1:353-6.

92 Powell S P Schwartz Rayment C Pharmacy-based adverse drug reaction surveillance program. Am J Hosp Pharmacy 1982; 39(11): 1963-4.

93 Fox RH R MacGibbon Davies L Problems of the old and the cold. BMJ 1973; 1:21-4.